Penn State Participates in ALIVE Trial Investigating Non-invasive Alternatives to Heart Failure Surgery

Penn State Participates in ALIVE Trial Investigating Non-invasive Alternatives to Heart Failure Surgery

Heart failure affects 6.2 million adults in the United States alone annually. Now at Penn State Health and Penn State College of Medicine, cardiologists, cardiac surgeons and researchers investigate a less invasive treatment for this dangerous condition impacting so many people. This novel therapy doesn’t involve an open heart surgery but rather involves excluding damaged heart tissue, the result of previous heart attacks, from the rest of the heart so that the organ can function more efficiently. Known as the ALIVE trial, the study investigates the use of the BioVentrix Revivent TC Transcatheter Ventricular Enhancement System.

Heart disease is the leading cause of death for both men and women in America, leading to about one in every four death, reports the U.S. Centers for Disease Control and Prevention (CDC). This condition results when the heart cannot pump blood and oxygen sufficiently to the body. The result of a heart attack includes symptoms such as fatigue, shortness of breath, and other physical constraints experienced by the patient, reports Penn State News.  Treatment options for those individuals experiencing heart failure include open heart surgery for the implant...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee